根据港交所最新文件显示,摩根大通在再鼎医药的持股比例出现显著变动。截至1月12日,其长期持仓比例从原先的5.11%缩减至4.46%,减持幅度达0.65个百分点。此次股权结构调整引发市场对机构投资者策略转向的关注。
根据港交所最新文件显示,摩根大通在再鼎医药的持股比例出现显著变动。截至1月12日,其长期持仓比例从原先的5.11%缩减至4.46%,减持幅度达0.65个百分点。此次股权结构调整引发市场对机构投资者策略转向的关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.